Golden Biotechnology Corporation (TPEX:4132)
Taiwan · Delayed Price · Currency is TWD 17.50
-0.45 (-2.51%)
Jan 22, 2026, 2:07 PM CST
Golden Biotechnology Market Cap
Golden Biotechnology has a market cap or net worth of 2.91 billion as of January 21, 2026. Its market cap has increased by 13.61% in one year.
Market Cap
2.91B
Enterprise Value
3.18B
Revenue
44.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.50
Market Cap Chart
Since May 26, 2010, Golden Biotechnology's market cap has increased from 1.15B to 2.91B, an increase of 153.88%. That is a compound annual growth rate of 6.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.91B | -25.36% |
| Dec 31, 2025 | 3.90B | 54.66% |
| Dec 31, 2024 | 2.52B | -54.81% |
| Dec 29, 2023 | 5.58B | -34.69% |
| Dec 30, 2022 | 8.55B | -50.08% |
| Dec 30, 2021 | 17.12B | 165.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Lin BioScience | 31.15B |